ZAL-70531-18324
3 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 558 / MN
- Registered
- 2022-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Dose 1 — Moderna
-
2021-02-11
Dose 2 — Moderna
-
2022-02-09
Dose 3 — Pfizer-BioNTech
-
2022-02-11
Registered in v-safe
-
2022-02-11
Survey response — days 1–6 daily, dose 3MedDRA: Pregnancy — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-02-12
- 2022-02-14
- 2022-02-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | No |
| 2 | 2021-02-11 | Moderna | No |
| 3 | 2022-02-09 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release